908 Devices Inc. offers a suite of purpose-built handheld and desktop mass spectrometry (Mass Spec) devices for the point of need chemical and biochemical analysis. The Company's Mass Spec devices are used at the point of need to interrogate unknown and invisible materials and provide answers to address problems in life sciences research, bioprocessing, industrial biotechnology, forensics and adjacent markets. Its products include MX908, Rebel, ZipChip, Maven and Maverick. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. The Rebel is a small desktop analyzer providing real-time information on the extracellular environment in bioprocesses.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļMASS
āļāļ·āđāļāļāļĢāļīāļĐāļąāļ908 Devices Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļDec 18, 2020
āļāļĩāļāļĩāđāļDr. Kevin J. Knopp, Ph.D.
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ246
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļDec 18
āļāļĩāđāļāļĒāļđāđ645 Summer Street
āđāļĄāļ·āļāļBOSTON
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ Global Market Consolidated
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ02210
āđāļāļĢāļĻāļąāļāļāđ19787294478
āđāļ§āđāļāđāļāļāđhttps://908devices.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļMASS
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļDec 18, 2020
āļāļĩāļāļĩāđāļDr. Kevin J. Knopp, Ph.D.
Dr. Kevin J. Knopp, Ph.D.
Dr. Kevin J. Knopp, Ph.D.
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
Dr. Christopher D. Brown, Ph.D.
Dr. Christopher D. Brown, Ph.D.
Co-Founder, Director
Mr. Mark Spoto
Independent Director
Mr. Fenel M. Eloi
Independent Director
Mr. Keith L. Crandell
Independent Director
Ms. Michele M. Leonhart
Independent Director
Jon Frattaroli
Vice President - Strategy
Vice President - Strategy
Mr. E. Kevin Hrusovsky
Independent Chairman of the Board
Independent Chairman of the Board
Ms. Barbara Russo
Vice President - Marketing and Corporate Communications
Vice President - Marketing and Corporate Communications
Mr. Jeffrey P. (Jeff) George
Mr. Jeffrey P. (Jeff) George
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Dr. Kevin J. Knopp, Ph.D.
Dr. Kevin J. Knopp, Ph.D.
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
Dr. Christopher D. Brown, Ph.D.
Dr. Christopher D. Brown, Ph.D.
Co-Founder, Director
Mr. Mark Spoto
Independent Director
Mr. Fenel M. Eloi
Independent Director
Mr. Keith L. Crandell
Independent Director
Ms. Michele M. Leonhart
Independent Director
ARK Genomic Revolution ETF
SPDR S&P Kensho Future Security ETF
SPDR S&P Kensho New Economies Composite ETF
Avantis US Small Cap Equity ETF
Proshares Ultra Russell 2000
Schwab U.S. Small-Cap ETF
ProShares UltraPro Russell2000
iShares Russell 2000 Growth ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
ARK Genomic Revolution ETF
āļŠāļąāļāļŠāđāļ§āļ1.81%
SPDR S&P Kensho Future Security ETF
āļŠāļąāļāļŠāđāļ§āļ1.05%
SPDR S&P Kensho New Economies Composite ETF
āļŠāļąāļāļŠāđāļ§āļ0.53%
iShares Micro-Cap ETF
āļŠāļąāļāļŠāđāļ§āļ0.04%
Avantis US Small Cap Equity ETF
āļŠāļąāļāļŠāđāļ§āļ0.02%
Proshares Ultra Russell 2000
āļŠāļąāļāļŠāđāļ§āļ0.01%
iShares Russell 2000 ETF
āļŠāļąāļāļŠāđāļ§āļ0.01%
Schwab U.S. Small-Cap ETF
āļŠāļąāļāļŠāđāļ§āļ0.01%
ProShares UltraPro Russell2000
āļŠāļąāļāļŠāđāļ§āļ0.01%
iShares Russell 2000 Growth ETF
āļŠāļąāļāļŠāđāļ§āļ0.01%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ